| dc.contributor.author | Celik, Turgay | |
| dc.contributor.author | Iyisoy, Atila | |
| dc.contributor.author | Dogru, M. Tolga | |
| dc.contributor.author | Isik, Ersoy | |
| dc.date.accessioned | 2020-06-25T17:48:38Z | |
| dc.date.available | 2020-06-25T17:48:38Z | |
| dc.date.issued | 2009 | |
| dc.identifier.issn | 0167-5273 | |
| dc.identifier.uri | https://doi.org/10.1016/j.ijcard.2007.07.011 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12587/4511 | |
| dc.description | Celik, Turgay/0000-0001-8418-0130 | en_US |
| dc.description | WOS: 000262978900017 | en_US |
| dc.description | PubMed: 17692950 | en_US |
| dc.description.abstract | Stent strut fracture (SSF) after drug-eluting stent (DES) implantation may be an important complication after DES implantation particularly in patients undergoing sirolimus eluting stent implantation. Since SSF is a highly relevant adverse event which can result in in-stent restenosis and thrombosis, we belive that DES with flexible stent platform or biodegradable DES may be needed to prevent this potential catastrophic complication. (C) 2007 Elsevier Ireland Ltd. All rights reserved. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Elsevier Ireland Ltd | en_US |
| dc.relation.isversionof | 10.1016/j.ijcard.2007.07.011 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Drug-eluting stents | en_US |
| dc.subject | Stent fracture | en_US |
| dc.subject | Restenosis | en_US |
| dc.title | Coronary stent strut fracture after drug-eluting stent implantation: A newly recognized complication | en_US |
| dc.type | letter | en_US |
| dc.contributor.department | Kırıkkale Üniversitesi | en_US |
| dc.identifier.volume | 132 | en_US |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.startpage | 121 | en_US |
| dc.identifier.endpage | 122 | en_US |
| dc.relation.journal | International Journal Of Cardiology | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
